Recombinant Human PNPLA3 293 Cell Lysate

• Cat.No.: PNPLA3-3068HCL

Specification

• Description: Antigen standard for patatin-like phospholipase domain containing 3 (PNPLA3) is a lysate prepared from HEK293T cells transiently transfected with a TrueORF gene-carrying pCMV plasmid and then lysed in RIPA Buffer. Protein concentration was determined using a colorimetric assay. The antigen control carries a C-terminal Myc/DDK tag for detection.
• Source: HEK 293 cells
• Species: Human
• Components: This product includes 3 vials: 1 vial of gene-specific cell lysate, 1 vial of control vector cell lysate, and 1 vial of loading buffer. Each lysate vial contains 0.1 mg lysate in 0.1 ml (1 mg/ml) of RIPA Buffer (50 mM Tris-HCl pH7.5, 250 mM NaCl, 5 mM EDTA, 50 mM NaF, 1% NP40). The loading buffer vial contains 0.5 ml 2X SDS Loading Buffer (125 mM Tris-Cl, pH6.8, 10% glycerol, 4% SDS, 0.002% Bromophenol blue, 5% beta-mercaptoethanol).
• Size: 0.1 mg
• Storage Instruction: Store at -80°C. Minimize freeze-thaw cycles. After addition of 2X SDS Loading Buffer, the lysates can be stored at -20°C. Product is guaranteed 6 months from the date of shipment.
• Applications: ELISA, WB, IP. WB: Mix equal volume of lysates with 2X SDS Loading Buffer. Boil the mixture for 10 min before loading (for membrane protein lysates, incubate the mixture at room temperature for 30 min). Load 5 ug lysate per lane.

Gene Information

• Gene Name: PNPLA3 patatin-like phospholipase domain containing 3 [ Homo sapiens ]
• Official Symbol: PNPLA3
• Synonyms: PNPLA3; patatin-like phospholipase domain containing 3; adiponutrin , ADPN, C22orf20, chromosome 22 open reading frame 20; patatin-like phospholipase domain-containing protein 3; adiponutrin; dJ796I17.1; FLJ22012; iPLA2-epsilon; acylglycerol O-acyltransferase; calcium-independent phospholipase A2-epsilon; ADPN; C22orf20; iPLA(2)epsilon
• Gene ID: 80339
• mRNA Refseq: NM_025225
• Protein Refseq: NP_079501
• MIM: 609567
• UniProt ID: Q9NST1
• Chromosome Location: 22q13.31
• Pathway: Acylglycerol degradation, organism-specific biosystem; Acylglycerol degradation, conserved biosystem; Adipogenesis, organism-specific biosystem; Glycerolipid metabolism, organism-specific biosystem; Glycerolipid metabolism, conserved biosystem; Metabolic pathways, organism-specific biosystem
• Function: diolein transacylation activity; hydrolase activity; mono-olein transacylation activity; phospholipase A2 activity; retinyl-palmitate esterase activity; transferase activity, transferring acyl groups; triglyceride lipase activity

Reviews

03/21/2022

Manufacturers should ensure the consistency and quality of PNPLA3 protein products.

04/09/2017

The PNPLA3 protein offered by the manufacturer exhibits exceptional quality and is precisely tailored to meet my experimental requirements.

11/02/2016

Its purity, stability, and functionality make it an ideal choice for my research endeavors.

Q&As

Does PNPLA3 play a role in other health conditions beyond liver disease?

PNPLA3 primarily influences lipid metabolism and liver health, but there may be connections with other metabolic disorders.

Can changes in diet and lifestyle help individuals with PNPLA3-related liver conditions?

Yes, dietary and lifestyle modifications, such as weight loss and reduced alcohol consumption, can help manage liver diseases associated with PNPLA3 variants.

How does PNPLA3 affect liver fibrosis progression in NAFLD patients?

PNPLA3 variants may accelerate liver fibrosis in NAFLD, making it a potential marker for disease severity.

Can children inherit PNPLA3 variants from their parents?

Yes, PNPLA3 gene variants can be inherited from parents and can increase the risk of liver diseases in children.

Are there any medications or therapies targeting PNPLA3 for the treatment of liver diseases?

There are no specific drugs targeting PNPLA3, but therapies for liver diseases often take into account a patient's genetic profile, including PNPLA3 variants.